(EL) Estee Lauder Companies - Overview
Stock: Skincare, Makeup, Fragrance, Haircare, Tools
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.77% |
| Yield on Cost 5y | 0.54% |
| Yield CAGR 5y | -10.58% |
| Payout Consistency | 96.6% |
| Payout Ratio | 71.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 75.1% |
| Relative Tail Risk | -15.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.09 |
| Alpha | 32.16 |
| Character TTM | |
|---|---|
| Beta | 1.495 |
| Beta Downside | 1.766 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.85% |
| CAGR/Max DD | -0.32 |
Description: EL Estee Lauder Companies December 17, 2025
The Estée Lauder Companies (NYSE: EL) designs, manufactures, markets, and sells prestige skin-care, makeup, fragrance, and hair-care products worldwide, operating through a mix of department stores, specialty retailers, e-commerce platforms, and direct-to-consumer channels.
Its portfolio spans 25+ brands-including La Mer, Jo Malone London, Tom Ford, Clinique, M·A·C, The Ordinary, Aveda, and Too Faced-covering the full spectrum of personal-care categories from moisturizers and serums to perfumes and styling products.
Distribution is highly diversified: high-end department stores and perfumeries, duty-free outlets, upscale salons and spas, as well as growing online pure-player sites and the company’s own e-commerce portals.
Key recent metrics (FY 2023) show net sales of roughly $17.7 billion, a 9 % year-over-year increase driven largely by a 22 % rise in Asia-Pacific sales, and adjusted EPS of $6.80, reflecting strong margin expansion in the digital channel.
Sector-wide, the prestige beauty market is buoyed by rising consumer spending on premium personal-care, accelerated digital adoption, and a shift toward “clean” and “inclusive” product narratives; however, macro-level risks include inflation-driven discretionary cutbacks and currency volatility in emerging markets.
For a deeper, data-driven valuation framework, you may find ValueRay’s analyst tools worth a look.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -178.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.00 > 1.0 |
| NWC/Revenue: 12.86% < 20% (prev 12.29%; Δ 0.57% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.67b > Net Income -178.0m |
| Net Debt (7.96b) to EBITDA (1.59b): 5.02 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (364.8m) vs 12m ago 1.33% < -2% |
| Gross Margin: 74.35% > 18% (prev 0.73%; Δ 7362 % > 0.5%) |
| Asset Turnover: 74.51% > 50% (prev 76.80%; Δ -2.29% > 0%) |
| Interest Coverage Ratio: 1.96 > 6 (EBITDA TTM 1.59b / Interest Expense TTM 390.0m) |
Altman Z'' 3.53
| A: 0.10 (Total Current Assets 7.16b - Total Current Liabilities 5.27b) / Total Assets 19.63b |
| B: 0.59 (Retained Earnings 11.62b / Total Assets 19.63b) |
| C: 0.04 (EBIT TTM 766.0m / Avg Total Assets 19.70b) |
| D: 0.68 (Book Value of Equity 10.55b / Total Liabilities 15.60b) |
| Altman-Z'' Score: 3.53 = A |
Beneish M -3.16
| DSRI: 1.06 (Receivables 1.66b/1.61b, Revenue 14.68b/15.18b) |
| GMI: 0.98 (GM 74.35% / 73.08%) |
| AQI: 0.92 (AQ_t 0.37 / AQ_t-1 0.40) |
| SGI: 0.97 (Revenue 14.68b / 15.18b) |
| TATA: -0.09 (NI -178.0m - CFO 1.67b) / TA 19.63b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of EL shares?
Over the past week, the price has changed by -13.71%, over one month by -8.36%, over three months by +13.74% and over the past year by +57.53%.
Is EL a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 23
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the EL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109 | 9.6% |
| Analysts Target Price | 109 | 9.6% |
| ValueRay Target Price | 99.8 | 0.3% |
EL Fundamental Data Overview February 07, 2026
P/S = 2.4525
P/B = 8.6411
P/EG = 2.9833
Revenue TTM = 14.68b USD
EBIT TTM = 766.0m USD
EBITDA TTM = 1.59b USD
Long Term Debt = 7.31b USD (from longTermDebt, last fiscal year)
Short Term Debt = 416.0m USD (from shortTermDebt, last quarter)
Debt = 11.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.96b USD (from netDebt column, last quarter)
Enterprise Value = 43.94b USD (35.98b + Debt 11.04b - CCE 3.08b)
Interest Coverage Ratio = 1.96 (Ebit TTM 766.0m / Interest Expense TTM 390.0m)
EV/FCF = 38.65x (Enterprise Value 43.94b / FCF TTM 1.14b)
FCF Yield = 2.59% (FCF TTM 1.14b / Enterprise Value 43.94b)
FCF Margin = 7.75% (FCF TTM 1.14b / Revenue TTM 14.68b)
Net Margin = -1.21% (Net Income TTM -178.0m / Revenue TTM 14.68b)
Gross Margin = 74.35% ((Revenue TTM 14.68b - Cost of Revenue TTM 3.77b) / Revenue TTM)
Gross Margin QoQ = 76.55% (prev 73.37%)
Tobins Q-Ratio = 2.24 (Enterprise Value 43.94b / Total Assets 19.63b)
Interest Expense / Debt = 0.74% (Interest Expense 82.0m / Debt 11.04b)
Taxrate = 21.0% (US default 21%)
NOPAT = 605.1m (EBIT 766.0m * (1 - 21.00%))
Current Ratio = 1.36 (Total Current Assets 7.16b / Total Current Liabilities 5.27b)
Debt / Equity = 2.74 (Debt 11.04b / totalStockholderEquity, last quarter 4.03b)
Debt / EBITDA = 5.02 (Net Debt 7.96b / EBITDA 1.59b)
Debt / FCF = 7.00 (Net Debt 7.96b / FCF TTM 1.14b)
Total Stockholder Equity = 4.03b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.90% (Net Income -178.0m / Total Assets 19.63b)
RoE = -4.41% (Net Income TTM -178.0m / Total Stockholder Equity 4.03b)
RoCE = 6.75% (EBIT 766.0m / Capital Employed (Equity 4.03b + L.T.Debt 7.31b))
RoIC = 5.33% (NOPAT 605.1m / Invested Capital 11.35b)
WACC = 8.88% (E(35.98b)/V(47.03b) * Re(11.42%) + D(11.04b)/V(47.03b) * Rd(0.74%) * (1-Tc(0.21)))
Discount Rate = 11.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.66%
[DCF Debug] Terminal Value 66.35% ; FCFF base≈1.14b ; Y1≈748.5m ; Y5≈341.5m
Fair Price DCF = N/A (negative equity: EV 5.79b - Net Debt 7.96b = -2.17b; debt exceeds intrinsic value)
EPS Correlation: -28.19 | EPS CAGR: -18.31% | SUE: 0.34 | # QB: 0
Revenue Correlation: -29.37 | Revenue CAGR: -0.04% | SUE: 0.00 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.68 | Chg30d=-0.057 | Revisions Net=+3 | Analysts=16
EPS current Year (2026-06-30): EPS=2.19 | Chg30d=+0.027 | Revisions Net=+8 | Growth EPS=+45.0% | Growth Revenue=+4.6%
EPS next Year (2027-06-30): EPS=3.00 | Chg30d=+0.072 | Revisions Net=+7 | Growth EPS=+37.2% | Growth Revenue=+4.4%